Incidence and management of malignant digestive endocrine tumours in a well defined French population.
about
Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value.Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine: Case report.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.Extensive multiarterial resection attending total duodenopancreatectomy and adrenalectomy for MEN-1-associated neuroendocrine carcinomas.Pancreatic insulinoma combined with glucagon positive cell: A case report.Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors: a systematic review and meta analysisPancreatic neuroendocrine tumors: approach to treatment with focus on sunitinibPancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.Management and prognosis of pancreatic cancer over a 30-year period.Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survivalEpidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria.A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours.Systemic chemotherapy with FOLFOX in metastatic grade 1/2 neuroendocrine cancerThe prognostic influence of the proliferative discordance in metastatic pancreatic neuroendocrine carcinoma revealed by peptide receptor radionuclide therapy: Case report and review of literatureManagement of gastric neuro-endocrine tumours in a large French national cohort (GTE).Flushing in (neuro)endocrinology.Differential diagnosis between pancreatic neuroendocrine and solid pseudopapillary neoplasms on endoscopic ultrasound-guided fine-needle aspiration. An immunohistochemical studyPrognostic impact of p16 and p21 on gastroenteropancreatic neuroendocrine tumors.Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection.Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?Clinicopathological Characteristics of the primary and metastatic Hepatic Neuroendocrine Tumors and the relevant Prognosis-Related Factors: A Retrospective Study of 81 Cases in a Single Chinese Center.Young patient age as the cause of delayed diagnosis of gastrointestinal carcinoma.Surgical treatment of pancreatic endocrine tumours in Italy: results of a prospective multicentre study of 262 cases
P2860
Q30249051-7AD3B9F0-0D73-4098-99D6-18B482C434C5Q31095566-1198A1D9-EBE9-43C0-96FF-47E463E26A60Q33745867-5FD4EE2E-05B1-4EE7-B532-08510F5865D1Q34063746-30D935BE-6076-4BD4-AC0D-D1EA626CA420Q34248466-DFD96D95-F40A-4884-B596-CD562B69584BQ34387994-390B3416-518C-43F3-9903-6F0206ABAC58Q34685863-62F4A128-04DF-451F-9CAB-40B86CF4F9C3Q35763588-17F86996-4BB9-4083-AAAE-5DC6FF332AFBQ36129201-B5626388-2B4A-413C-8562-F81C9548AA76Q36638258-ACBEDA69-429A-4332-B1A5-CBF283673C98Q36736778-8ED5C203-5C30-49D7-BCE3-FDE7FED8FE98Q36950937-88B80777-4397-4D11-985E-50E2A9E9C81FQ37130616-DAFD267F-CBA2-426E-AA0B-1DEECC725594Q37175960-E11A98BF-87C6-4719-A747-2D91EA4D225DQ37287408-6836A5EC-CEE4-4E66-995D-E95E78FEC81DQ37326199-B5B1CA35-1F75-43DF-8E85-377997DC4906Q37333811-579EAD6D-6FA0-4757-AC89-B3B15D975053Q37361194-EB9C4477-0A2F-4E6F-9FFF-4AD4939E2B8BQ37594074-BBD01F5A-E6DA-4B9B-970C-8DD3516BA292Q37646677-658DD43D-8658-4D5E-AC78-648AD2BABCB5Q38701102-B692C1FD-CB2F-4B88-8813-618402F69C2EQ39016266-2F6FFE26-1C3E-42CC-9867-3FDFC715CC81Q41062653-AAE5D41B-232F-4194-919C-9B345F00FE18Q42132289-B06D757E-B87A-47B0-922A-E735300BFA3FQ44647880-35CA5959-1FAC-4E91-8D28-F5DD7F87B827Q45902785-EF0CCBD4-59A3-4847-812A-B814F3C7763BQ47140426-9D3F1417-A4D0-49C9-9DF2-222C1C334B8AQ50301012-F5C49845-ED85-4B11-BF9A-4E327D26857CQ50924479-5DEC2E21-DD7E-4172-8CA0-5851D5B5CCB3Q57820051-EC57AEF4-6DD6-4DD8-BD38-17C7D58ACE2E
P2860
Incidence and management of malignant digestive endocrine tumours in a well defined French population.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Incidence and management of ma ...... ell defined French population.
@ast
Incidence and management of ma ...... ell defined French population.
@en
type
label
Incidence and management of ma ...... ell defined French population.
@ast
Incidence and management of ma ...... ell defined French population.
@en
prefLabel
Incidence and management of ma ...... ell defined French population.
@ast
Incidence and management of ma ...... ell defined French population.
@en
P2093
P2860
P356
P1433
P1476
Incidence and management of ma ...... ell defined French population.
@en
P2093
P2860
P304
P356
10.1136/GUT.2003.026401
P407
P577
2004-04-01T00:00:00Z